Common Shares Outstanding: The number of class A shares currently held by investors.
Swedish Orphan Biovitrum (BIOVF) had Common Shares Outstanding of 347.29M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$837.53M |
|
$117.16M |
|
$195.34M |
|
$642.19M |
|
$663.87M |
|
$173.66M |
|
$-22.86M |
|
$150.91M |
|
$150.91M |
|
$117.27M |
|
$117.27M |
|
$117.27M |
|
$117.27M |
|
$173.66M |
|
$305.87M |
|
346.18M |
|
350.06M |
|
$0.34 |
|
$0.34 |
|
| Balance Sheet Financials | |
$1.86B |
|
$173.66M |
|
$6.99B |
|
$8.85B |
|
$2.13B |
|
$905.98M |
|
$2.21B |
|
$4.34B |
|
$4.51B |
|
$-2.03B |
|
$4.51B |
|
|
Common Shares Outstanding |
347.29M |
| Cash Flow Statement Financials | |
$324.46M |
|
$-974.44M |
|
$649.66M |
|
$111.18M |
|
$115.56M |
|
$4.38M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
0.17 |
|
0.41 |
|
76.68% |
|
20.73% |
|
20.73% |
|
-- |
|
18.02% |
|
13.99% |
|
$324.46M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.28 |
|
0.79 |
|
113.52 |
|
2.60% |
|
-5.77% |
|
1.32% |
|
2.16% |
|
$13.00 |
|
$0.93 |
|
$0.93 |
|